by Agilent Technologies
Polaris HPLC Columns
Performs Well Under Aqueous Conditions
In areas like drug discovery where target compounds are increasingly polar, it is critical to have a reversed-phase column that performs well under aqueous conditions. Retention is critical, but cannot come with troublesome secondary interactions. Likewise, phase collapse and shifting retention times need to be avoided. The answer is our Polaris line of polar modified columns.
| Vendor | Agilent Technologies | Pore size | 180 |
| Brand | Agilent Polaris | Surface Area | 200 |
| Modifification | Silica/C18 | Carbon Load, % | 13.8 |
| Mode | Reversed-Phase | Endcapped | Yes |
| Particle Size | Operating Temperature | 60 | |
| Length | pH stability to | 10.0 | |
| Internal Diameter |
| Vendor | Brand | Mode | Modification | Int. diam. | Length | Particles | Pores | Price |
|---|---|---|---|---|---|---|---|---|
| GRACE | Vydac TP C18 | Reversed-Phase | Silica/C18 | 2.1 mm | 150 mm | 5.0 μm | 300 Å | On request |
| BISCHOFF | ProntoSIL 300-5-C18 ace-EPS | Reversed-Phase | Silica/C18 | 2.0 mm | 125 mm | 5.0 μm | 300 Å | On request |
| Fortis Technologies | FortisBIO C18 | Reversed-Phase | Silica/C18 | 0.075 mm | 50 mm | 3.0 μm | 300 Å | On request |
| LabHut | Cronusil-S ODS-1 | Reversed-Phase | Silica/C18 | 3.0 mm | 200 mm | 5.0 μm | 80 Å | 210.05 |
| Sepax Technologies | Sepax Bio 200 C18 | Reversed-Phase | Silica/C18 | 0.5 mm | 150 mm | 3.0 μm | 200 Å | On request |
| BISCHOFF | ProntoSIL Spheribond ODS2 | Reversed-Phase | Silica/C18 | 4.0 mm | 150 mm | 3.0 μm | 80 Å | On request |
| Greyhound | GenSphere ODS2 120 | Reversed-Phase | Silica/C18 | 4.0 mm | 150 mm | 5.0 μm | 120 Å | On request |
| Agilent Technologies | ZORBAX Eclipse XDB | Reversed-Phase | Silica/C18 | 21.0 mm | 150 mm | 5.0 μm | 80 Å | On request |
No customer reviews yet. Be the first to share your experience!